Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression.
about
Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition.Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3.Inhibition of HDACs-EphA2 Signaling Axis with WW437 Demonstrates Promising Preclinical Antitumor Activity in Breast Cancer.
P2860
Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhibition of breast cancer pr ...... wn-regulating EGFR expression.
@ast
Inhibition of breast cancer pr ...... wn-regulating EGFR expression.
@en
type
label
Inhibition of breast cancer pr ...... wn-regulating EGFR expression.
@ast
Inhibition of breast cancer pr ...... wn-regulating EGFR expression.
@en
prefLabel
Inhibition of breast cancer pr ...... wn-regulating EGFR expression.
@ast
Inhibition of breast cancer pr ...... wn-regulating EGFR expression.
@en
P2093
P2860
P356
P1476
Inhibition of breast cancer pr ...... own-regulating EGFR expression
@en
P2093
Feifei Yang
Jingjie Li
Zhengfang Yi
P2860
P304
P356
10.1111/BPH.13165
P407
P577
2015-06-12T00:00:00Z